HF
CNTB

HRT Financial’s Connect Biopharma Holdings CNTB Stock Holding History

HRT Financial’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-15,299
Closed -$40K – 4356
2026
Q1 		$40K Sell
15,299
-1,486
-9% -$3.87K ﹤0.01% 3479
2025
Q4 		$47K Buy
16,785
+6,328
+61% +$13.5K ﹤0.01% 2879
2025
Q3 		$15K Buy
+10,457
New +$18.5K ﹤0.01% 2728

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $192M AUM 23.02% 1-Year Est. Return
DMKJ
David M. Knott Jr $189M AUM 67.72% 1-Year Est. Return

HRT Financial's CNTB Position: Q2 2026 in Review

HRT Financial sold out of Connect Biopharma Holdings (CNTB) in Q2 2026, closing a stake of 15,299 shares — an estimated $40K sold.

HRT Financial first reported a position in CNTB in Q3 2025 and held it in 3 quarters. The position peaked at $47K in Q4 2025. 56 funds tracked by Wall St. Rank hold CNTB as of Q2 2026.

  • HRT Financial reported no remaining Connect Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • HRT Financial sold 15,299 Connect Biopharma Holdings shares in Q2 2026, an estimated $40K.
  • HRT Financial first reported a position in Connect Biopharma Holdings in Q3 2025 and held it in 3 quarters.
  • HRT Financial's Connect Biopharma Holdings position peaked at $47K in Q4 2025.
  • 56 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.